ID: ALA1084190

Max Phase: Preclinical

Molecular Formula: C76H117N25O21

Molecular Weight: 1716.93

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(C)C)C(=O)N[C@@H](CO)C(=O)O

Standard InChI:  InChI=1S/C76H117N25O21/c1-39(2)29-48(63(111)98-54(38-104)73(121)122)93-65(113)50(31-42-34-87-44-18-9-8-17-43(42)44)90-58(106)35-88-61(109)45(19-10-24-84-74(78)79)91-67(115)52(36-102)96-62(110)46(20-11-25-85-75(80)81)92-64(112)49(30-41-15-6-5-7-16-41)95-70(118)60(40(3)4)99-68(116)53(37-103)97-66(114)51(32-59(107)108)94-69(117)55-22-13-27-100(55)72(120)56-23-14-28-101(56)71(119)47(89-57(105)33-77)21-12-26-86-76(82)83/h5-9,15-18,34,39-40,45-56,60,87,102-104H,10-14,19-33,35-38,77H2,1-4H3,(H,88,109)(H,89,105)(H,90,106)(H,91,115)(H,92,112)(H,93,113)(H,94,117)(H,95,118)(H,96,110)(H,97,114)(H,98,111)(H,99,116)(H,107,108)(H,121,122)(H4,78,79,84)(H4,80,81,85)(H4,82,83,86)/t45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,60-/m0/s1

Standard InChI Key:  YDRPGVIGNOKVDQ-WDSADFJJSA-N

Associated Targets(non-human)

Hemagglutinin 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1716.93Molecular Weight (Monoisotopic): 1715.8856AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Matsubara T, Onishi A, Saito T, Shimada A, Inoue H, Taki T, Nagata K, Okahata Y, Sato T..  (2010)  Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.,  53  (11): [PMID:20476787] [10.1021/jm1002183]

Source